|Podcasts|November 25, 2021
Episode 96: Forging New Paths In Oncology
Author(s)Elaine Quilici, Miranda Schmalfuhs
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
Advertisement
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5